Utley W S, Mehendale H M
Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson 39216-4505.
J Biochem Toxicol. 1991 Summer;6(2):101-13. doi: 10.1002/jbt.2570060204.
Hepatocytes isolated from phenobarbital-pretreated and naive male Sprague-Dawley rats were preincubated with 80 microM N, N-bis (2-chloroethyl)-N-nitrosourea and subsequently exposed to varying concentrations of menadione. We observed that the reduced glutathione levels of the hepatocytes isolated from the sodium phenobarbital(PB)-pretreated, but not the naive rats, recovered to near-control levels after exposure to 200 microM menadione. Since this recovery occurred in the presence of N, N-bis (2-chloroethyl)-N-nitrosourea (an inhibitor of glutathione reductase), we hypothesized that this represented a PB-mediated increase in de novo synthesis of glutathione. To test this hypothesis and to further assess the possible contribution of glutathione reductase in the recovery of the glutathione levels, we preincubated hepatocytes isolated from PB-pretreated and naive rats with 2 mM buthionine sulfoximine, with or without N, N-bis (2-chloroethyl)-N-nitrosourea. Following exposure to menadione, samples were periodically removed for glutathione assessment. Consistent with our hypothesis, the addition of buthionine sulfoximine abrogated the ability of the PB-pretreated hepatocytes to restore glutathione levels following a menadione challenge. Buthionine sulfoximine in combination with N, N-bis (2-chloroethyl)-N-nitrosourea completely abolished hepatocellular glutathione homeostasis for all of the concentrations of menadione employed. The findings from this investigation underscore the importance of phenobarbital-mediated increases in glutathione synthesis, as well as the enhanced levels of glutathione reductase, in maintaining the pool of reduced glutathione and ultimately mitigating the consequences of oxidative stress. In addition, these findings suggest that PB pretreatment increases the reserve capacity of the hepatocyte for glutathione synthesis via a hitherto undescribed hormetic mechanism, a reserve expressed fully only on an oxidative stress of sufficient magnitude.
从经苯巴比妥预处理和未经处理的雄性斯普拉格 - 道利大鼠中分离出的肝细胞,先用80微摩尔/升的N,N - 双(2 - 氯乙基)-N - 亚硝基脲进行预孵育,随后暴露于不同浓度的甲萘醌中。我们观察到,从经苯巴比妥(PB)预处理的大鼠而非未经处理的大鼠中分离出的肝细胞,在暴露于200微摩尔/升甲萘醌后,其还原型谷胱甘肽水平恢复到接近对照水平。由于这种恢复是在存在N,N - 双(2 - 氯乙基)-N - 亚硝基脲(一种谷胱甘肽还原酶抑制剂)的情况下发生的,我们推测这代表了PB介导的谷胱甘肽从头合成增加。为了验证这一假设并进一步评估谷胱甘肽还原酶在谷胱甘肽水平恢复中的可能作用,我们用2毫摩尔/升的丁硫氨酸亚砜胺对从PB预处理和未经处理的大鼠中分离出的肝细胞进行预孵育,同时添加或不添加N,N - 双(2 - 氯乙基)-N - 亚硝基脲。在暴露于甲萘醌后,定期取出样本进行谷胱甘肽评估。与我们的假设一致,添加丁硫氨酸亚砜胺消除了PB预处理的肝细胞在甲萘醌刺激后恢复谷胱甘肽水平的能力。丁硫氨酸亚砜胺与N,N - 双(2 - 氯乙基)-N - 亚硝基脲联合使用,对于所采用的所有甲萘醌浓度,完全破坏了肝细胞内谷胱甘肽的稳态。这项研究结果强调了苯巴比妥介导的谷胱甘肽合成增加以及谷胱甘肽还原酶水平升高在维持还原型谷胱甘肽池以及最终减轻氧化应激后果方面的重要性。此外,这些发现表明,PB预处理通过一种迄今未描述的兴奋效应机制增加了肝细胞谷胱甘肽合成的储备能力,这种储备能力只有在足够强度的氧化应激时才会充分表现出来。